000			03584nam a2200421 i 4500
001			44938
003			BD-DhAAL
005			20251015104101.0
008			251015t2024 nyua b 001 0 eng d
010			_a 2023005637
020			_a9780826149329 _q(paperback)
020			_z9780826149336 _q(eBook)
035			_a22961459
040			_aDNLM/DLC _beng _erda _cDLC _dDLC _dBD-DhAAL
042			_apcc
050	0	0	_aRC271.C5 _bC3224 2024
060	0	0	_aQV 269
082	0	0	_a616.994061 _223
245	0	0	_aCancer pharmacology : _ban illustrated manual of anticancer drugs / _cedited by Ashkan Emadi, Judith E. Karp.
246	1	8	_aCancer pharmacology
250			_aSecond edition.
260			_aNew York, NY : _bSpringer Publishing Company, _cc2024.
300			_axvi, 454 pages : _bcolor illustrations ; _c26 cm
504			_aIncludes bibliographical references and index.
505	0		_aDrug Development in Oncology / Edward A. Sausville and Ashkan Emadi -- Pharmacogenomics / Milly Graveno -- Critical Components of Clinical Trials Development : From Bench to Bedside and Back / S. Percy Ivy, Richard F. Little, and Joshua F. Zeidner -- Drug Development and Regulatory Considerations / Vicky Hsu, Matthew D. Thompson, Donna Przepiorka, and Olanrewaju O. Okusanya -- Alkylating Agents / Ashkan Emadi and Edward A. Sausville -- Pyrimidine- and Purine-based Antimetabolites, Hydroxyurea, Asparaginases / Ashkan Emadi and Judith E. Karp -- Antimetabolites : Antifolates / Justin Lawson -- Antimitotics / Edward A. Sausville and Ashkan Emadi -- DNA Repair, Apoptotic Pathways, and CDK Inhibitors / Mira A. Kohorst and Scott H. Kaufmann -- Epigenetic Modulators / Sergiu Pasca and Lukasz P. Gondek -- Differentiating Agents and Microenvironment / Yuya Nagai and Gabriel Ghiaur -- Targeted Therapeutics (Small Molecules) / Yuchen (Jake) Liu and Ashkan Emadi -- Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer / Amy M. Fulton and Katherine H. R. Tkaczu -- Androgen Receptor Axis Targeting in the Treatment of Prostate Cancer / Vincent C. O. Njar and Arif Hussain -- Multiple Myeloma as a Paradigm for MultiTargeted Intervention / Kathryn Maples and Sagar Lonial -- Transplant-Related Agents : Focus on Graft vs. Host Disease Prevention and Treatment / Vedran Radojcic -- Monoclonal Antibodies Including Immunoconjugates, Antibody-Drug Conjugates, and Cytokine-Directed Agents / Alison Duffy and Ciera Bernhardi -- Immunotherapeutics : Immune Checkpoint Inhibitors, Vaccines, Bispecifics, and Engineered T Cells / Mark Yarchoan and Elizabeth Jaffee.
520			_a"We are living in an exciting time for cancer pharmacology. The fusion of multiple disciplines of basic and clinical science is creating effective, life-prolonging therapies for a growing number of malignancies. The progress is electrifying and the promise for patients is exhilarating!"--
526			_aPHR
650	1	2	_aAntineoplastic Agents _xpharmacology. _959602
650	2	2	_aNeoplasms _xdrug therapy. _938333
650	2	2	_aMolecular Targeted Therapy. _938334
650	2	2	_aPharmacy.
700	1		_aEmadi, Ashkan, _eeditor. _959603
700	1		_aKarp, Judith E., _eeditor. _959604
776	0	8	_iOnline version: _tCancer pharmacology _bSecond edition. _dNew York, NY : Springer Publishing Company, [2024] _z9780826149336 _w(DLC) 2023005638
942			_2ddc _cBK
999			_c47559 _d47559